SMR Stock Today, January 10: BofA Upgrade, Meta Nuclear Deal Lift Shares
SMR stock is back on traders’ screens after Bank of America raised its rating to Neutral and a sector boost tied to Meta’s record nuclear procurement. NuScale Power (SMR) was not part of Meta’s deal, but sentiment improved. The upgrade cites reduced project risk through the TVA development agreement. Shares recently traded near $18.78, with a day range of $17.34 to $19.55 and a 52‑week range of $11.08 to $57.42. We break down what this means for SMR stock today and what to watch next.
What’s Moving SMR on January 10
Bank of America shifted its view to Neutral, noting progress that lowers execution risk via NuScale’s TVA development agreement. The call stops short of a bullish stance because revenue remains small and reactors are not yet deployed. Still, rating relief and better visibility can draw generalist capital, which helped the bounce this week. See coverage of the move here: Why NuScale Power Stock Is Surging Higher Today.
Meta announced a record procurement of nuclear power, lifting interest across next‑gen nuclear. NuScale is not in that procurement, but the headline improved peer sentiment and highlighted long‑term demand for clean baseload power. That tailwind, paired with the rating change, supported SMR stock momentum. Read more context: Why NuScale Power Stock Was Moving Higher This Week.
Recent price sits near $18.78, below the 50‑day average of $22.83 and 200‑day of $30.56, showing the longer trend is still down. Volume hit about 68.6 million versus a 31.2 million average, signaling active participation. Intraday range of $17.34 to $19.55 shows volatility. For today, SMR stock trades heavy but liquid, and reactions to headlines are moving price quickly.
Key Fundamentals and Valuation
NuScale remains pre‑deployment. EPS is about -$2.14 and price-to-sales near 109x on tiny revenue per share of $0.38. Cash per share is roughly $4.68 with a current ratio near 1.62, which helps near‑term liquidity, but free cash flow per share is about -$1.91. Until firm orders convert, SMR stock rides headlines more than fundamentals.
Analysts show 3 Buy, 7 Hold, 1 Sell, for a Hold‑leaning consensus. The median target sits at $35, with a $20 low and $55 high. The next key checkpoint is earnings expected around March 2, 2026. Updates on backlog, cash runway, and TVA progress will shape the outlook for SMR stock.
At $18.78, the median target implies roughly 86% upside, while the high target implies about 193%. Those figures look large because today’s price reflects early-stage risk. Without deployed reactors and clear revenue scale, realization of targets depends on bookings, financing, and execution. SMR stock can rerate fast in either direction on those milestones.
Technical Picture and Risk Factors
Momentum has improved but is mixed. RSI sits near 56.3 and ADX around 26.5 suggests a strong trend. MACD histogram is positive, while CCI at 145.7 and Stochastic near 85.5 flash overbought. That combination points to short‑term strength, but SMR stock can cool quickly if news flow slows.
ATR near 1.83 signals wide swings. Bollinger levels show a middle band near 17.12 and upper near 21.30. Keltner’s middle is around 18.26 with an upper near 21.91. That sets a support zone around 17.1–17.3 and resistance near 21.3–21.9. Breaks could trigger momentum trades in SMR stock.
Watch for TVA milestones, new customer commitments, or federal support that improves financing. Clearer funding and a path to construction would ease execution risk. On the flip side, cash burn and potential dilution remain real. Meta’s nuclear move is positive for sentiment, but NuScale was not included, so SMR stock needs its own firm wins.
Final Thoughts
SMR stock is moving on two forces today: a Bank of America upgrade to Neutral that reduces perceived project risk, and sector interest tied to Meta’s nuclear procurement. Neither eliminates core challenges. NuScale still has no deployed reactors and little revenue, so execution and funding remain the swing factors. For traders, volatility and defined levels around 17 and 21 offer setups. For investors, we would track TVA milestones, firm orders, financing clarity, and the March 2, 2026 earnings update. Position sizes should reflect high risk and the potential for sharp moves in both directions.
FAQs
Why is SMR stock moving today?
Two catalysts are in play. Bank of America upgraded NuScale to Neutral, citing lower execution risk via the TVA development agreement. Also, Meta’s large nuclear procurement boosted sector interest, even though NuScale is not part of that deal. Together, they improved sentiment and trading activity.
Is NuScale part of Meta’s nuclear deal?
No. NuScale was not included in Meta’s procurement. The news helps sentiment for nuclear power and the broader theme of clean baseload, but it does not add revenue for NuScale. Investors should separate sector headlines from company‑specific orders and funding.
Is SMR stock a buy right now?
It suits speculative investors who accept high risk. The Street shows a Hold‑leaning view, with a $35 median target. Upside depends on orders, financing, and TVA progress. Without deployed reactors, execution risk is high. Consider staged entries and strict risk controls.
What price levels should I watch on SMR stock?
Near‑term support sits around 17.1–17.3. Resistance appears near 21.3–21.9. The 50‑day average at about 22.83 and 200‑day at 30.56 are trend gauges. An ATR near 1.83 signals large swings. Breaks above or below these zones can accelerate momentum.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
